RESULTS
From March 14, 2020 to May 14, 2020, we evaluated 82 cases who consulted
the adult hematology unit. The median age of the patients was 49,5
(18-93). Forty-six (56,1%) of the patients were female and 36 of the
patients (43,9%) were males. The number of the consultation requested
from outpatients was 46 (56,1%), while the inpatients were 36 (43,9%).
The clinic that requested the most consultation was gynecology with 17
of patients (20,7%). Distribution of the clinics requested a
consultation is listed in Table 1.
Eight patients were suspected with COVID-19 because of clinical signs,
such as fever, cough and headache. Only two of these patients had
COVID-positive according to PCR results. The frequency of suspicion of
the COVID-19 was statistically significantly higher in patients with
previously hematological diagnosed and also in consultation requested
from inpatients (p=0,018 and p=0,019, respectively). Table 2 shows
distribution associated with suspected COVID-19 patients according to
features of the hematological disease and outpatient or inpatient.
Seven of the patients previously hematologic diagnosed were Hodgkin’s
lymphoma, chronic lymphocytic leukemia (CLL), myelodysplastic syndrome
(MDS), idiopathic thrombocytopenic purpura (ITP), multiple myeloma,
Bernard- Soulier syndrome and hereditary spherocytosis with one patient
in each of them. In the other 75 patients, any clinical pathologic
features were not found in 11 patients and diagnostic evaluation had not
been finished yet in 12 patients. The most common diagnosis was
drug-related cytopenia with 11 patients (20,4%) of the 54 patients.
Distribution of diagnoses is presented in Table 3. The less common
diagnoses were presented like “the other” with one patient each of the
diagnoses. In Table 3, diagnosis of Budd-Chiari syndrome, portal ven
thrombosis, retinal ven thrombosis and hereditary thrombophilia were
entitled under the upside of “thrombosis”.